Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 925

1.

Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.

Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA.

Cancer. 2004 Oct 1;101(7):1490-500.

PMID:
15378477
[PubMed - indexed for MEDLINE]
Free Article
2.

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.

Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Cushing-Haugen KL, Daling JR.

JAMA. 2003 Jun 25;289(24):3254-63.

PMID:
12824206
[PubMed - indexed for MEDLINE]
3.

Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study.

Tjønneland A, Christensen J, Thomsen BL, Olsen A, Overvad K, Ewertz M, Mellemkjaer L.

Cancer. 2004 Jun 1;100(11):2328-37.

PMID:
15160335
[PubMed - indexed for MEDLINE]
Free Article
4.

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.

J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65.

PMID:
15601642
[PubMed - indexed for MEDLINE]
Free Article
5.

Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.

Suzuki R, Ye W, Rylander-Rudqvist T, Saji S, Colditz GA, Wolk A.

J Natl Cancer Inst. 2005 Nov 2;97(21):1601-8.

PMID:
16264180
[PubMed - indexed for MEDLINE]
Free Article
6.

Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.

Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge RM.

J Natl Cancer Inst. 2005 Sep 7;97(17):1254-61.

PMID:
16145046
[PubMed - indexed for MEDLINE]
Free Article
7.

Risk factors for hormone receptor-defined breast cancer in postmenopausal women.

Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2482-8.

PMID:
17164374
[PubMed - indexed for MEDLINE]
Free Article
8.

Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.

Ritte R, Lukanova A, Berrino F, Dossus L, Tjønneland A, Olsen A, Overvad TF, Overvad K, Clavel-Chapelon F, Fournier A, Fagherazzi G, Rohrmann S, Teucher B, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Sieri S, Panico S, Tumino R, Vineis P, Quirós JR, Buckland G, Sánchez MJ, Amiano P, Chirlaque MD, Ardanaz E, Sund M, Lenner P, Bueno-de-Mesquita B, van Gils CH, Peeters PH, Krum-Hansen S, Gram IT, Lund E, Khaw KT, Wareham N, Allen NE, Key TJ, Romieu I, Rinaldi S, Siddiq A, Cox D, Riboli E, Kaaks R.

Breast Cancer Res. 2012 May 14;14(3):R76.

PMID:
22583394
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Risk factors for breast cancer according to estrogen and progesterone receptor status.

Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE.

J Natl Cancer Inst. 2004 Feb 4;96(3):218-28.

PMID:
14759989
[PubMed - indexed for MEDLINE]
Free Article
10.

Type and duration of exogenous hormone use affects breast cancer histology.

Kumar AS, Cureton E, Shim V, Sakata T, Moore DH, Benz CC, Esserman LJ, Hwang ES.

Ann Surg Oncol. 2007 Feb;14(2):695-703. Epub 2006 Nov 14.

PMID:
17103262
[PubMed - indexed for MEDLINE]
11.

Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.

Bardia A, Hartmann LC, Vachon CM, Vierkant RA, Wang AH, Olson JE, Sellers TA, Cerhan JR.

Arch Intern Med. 2006 Dec 11-25;166(22):2478-83.

PMID:
17159013
[PubMed - indexed for MEDLINE]
12.

Unopposed estrogen therapy and the risk of invasive breast cancer.

Chen WY, Manson JE, Hankinson SE, Rosner B, Holmes MD, Willett WC, Colditz GA.

Arch Intern Med. 2006 May 8;166(9):1027-32.

PMID:
16682578
[PubMed - indexed for MEDLINE]
13.

Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.

Fournier A, Fabre A, Mesrine S, Boutron-Ruault MC, Berrino F, Clavel-Chapelon F.

J Clin Oncol. 2008 Mar 10;26(8):1260-8. doi: 10.1200/JCO.2007.13.4338.

PMID:
18323549
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Estrogen and progesterone receptor status in breast cancer: effect of oral contraceptive pills and hormone replacement therapy.

Tewari M, Pradhan S, Singh U, Shukla HS.

Breast. 2007 Oct;16(5):540-5. Epub 2007 Jun 22.

PMID:
17587581
[PubMed - indexed for MEDLINE]
15.

Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.

Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Marchbanks PA, Coates RJ, Norman SA, Weiss LK, Ursin G, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Spirtas R.

Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1175-81.

PMID:
14652277
[PubMed - indexed for MEDLINE]
Free Article
16.

Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study.

Suzuki R, Rylander-Rudqvist T, Ye W, Saji S, Wolk A.

Int J Cancer. 2006 Oct 1;119(7):1683-9.

PMID:
16646051
[PubMed - indexed for MEDLINE]
17.

Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.

Dunnwald LK, Rossing MA, Li CI.

Breast Cancer Res. 2007;9(1):R6.

PMID:
17239243
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Short-term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma.

Prasad R, Boland GP, Cramer A, Anderson E, Knox WF, Bundred NJ.

Cancer. 2003 Dec 15;98(12):2539-46.

PMID:
14669271
[PubMed - indexed for MEDLINE]
Free Article
20.

Hormone replacement therapy and high S phase in breast cancer.

Cobleigh MA, Norlock FE, Oleske DM, Starr A.

JAMA. 1999 Apr 28;281(16):1528-30.

PMID:
10227323
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk